Home/Filings/4/0000899243-21-022989
4//SEC Filing

Stimart Tryn 4

Accession 0000899243-21-022989

CIK 0001703057other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:01 PM ET

Size

6.2 KB

Accession

0000899243-21-022989

Insider Transaction Report

Form 4
Period: 2021-06-09
Stimart Tryn
Chief Legal Officer
Transactions
  • Sale

    Common Shares

    2021-06-09$25.50/sh1,000,000$25,500,000250 total
Holdings
  • Common Shares

    (indirect: By Spouse)
    250
Footnotes (2)
  • [F1]On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
  • [F2]The sale of the shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act"), to the extent of 500 Shares, with the purchase by the Reporting Person of 250 Shares at a price of $20 per share on December 15, 2020, and the purchase by the Reporting Person's spouse of 250 Shares at a price of $20 per share on December 15, 2020, as reported previously on the Reporting Person's Form 4 filed on December 17, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act.

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834424

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:01 PM ET
Size
6.2 KB